Articles overview

Measurable Residual Disease and Decision-Making in Multiple Myeloma

An excellent, must-read review article has been published by Benjamin Derman and Rafael Fonseca with a deep-dive into the evolving...
Read more

Hypogammaglobulinemia newsletter

Welcome to this edition of the Sanofi quarterly newsletter! These newsletters, created by Sanofi, aim to provide education to healthcare...
Read more

Risk stratification in patients with monoclonal Gammopathies

Thorsteinsdóttir, S., Gíslason, G., Aspelund, T. et al. Prevalence of smoldering multiple myeloma based on nationwide screening. Nature Medicine. 2023;...
Read more

Review: NK cell therapy in relapsed refractory multiple myeloma

Read the review about NK cell therapy in relaped refractory multiple Myeloma from Science direct
Read more

Personalized Medicine

Patient-derived multiple myeloma 3D models for personalized medicine
Read more